Raphael Pharmaceutical Inc. (RAPH): Cash & Equivalents
$19.0K
As of 2024-12-31
-50.1%
3-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2024-12-31 | $19.0K | -91.7% | 2025-03-31, Balance as of period end |
| 2023-12-31 | $230.0K | -20.1% | 2025-03-31, Balance as of period end |
| 2022-12-31 | $288.0K | +88.2% | 2024-03-28, Balance as of period end |
| 2021-12-31 | $153.0K | +61.1% | 2023-05-25, Balance as of period end |
| 2020-12-31 | $95.0K | n/a | 2022-03-30, Balance as of period end |